Masimo filed a lawsuit against its founder and former CEO Joe Kiani and investment firm RTW Investments, accusing them of ...

The man who acquired Sound United and founded US Health Company Masimo has been sacked by his own board, and to top that that ...

The news led to a stock surge on expectations that forthcoming data for the company’s experimental gene therapy for Rett ...

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and ...

Neurogene shares reached a 52-week high after the genetic medicine company announced an oversubscribed private placement of about $200 million. The stock was up 44% to $66.55 on Monday, with an ...

Fintel reports that on November 1, 2024, Jones Trading downgraded their outlook for ESSA Pharma (NasdaqCM:EPIX) from Buy to ...

American venture capitalists are increasingly building U.S.-based companies from scratch to commercialize drugs developed in ...

GlycoMimetics (GLYC) announced it has entered into an acquisition agreement with Crescent Biopharma, a privately held biotechnology company.

Even after they lose exclusivity on the drugs, Woody Stileman, managing director at RTW Investments LP, the Investment Manager of RTW Biotech Opportunities Ltd, expects domination from the two firms.

RTW Investments, Blackstone Multi-Asset Investing, Frazier Life Sciences, Commodore Capital, Perceptive Advisers, Deep Track Capital, Boxer Capital Management, Soleus, Logos Capital, Driehaus ...

RTW Investments, Blackstone Multi-Asset Investing, Frazier Life Sciences, Commodore Capital, Perceptive Advisers, Deep Track Capital, Boxer Capital Management, Soleus, Logos Capital, Driehaus Capital ...